ABSTRACT OF THE WEEK

The Veterinary Clinics of North America. Food animal practice
Volume 37 | Issue 3 (November 2021)

Registered Medicinal Products for Use in Honey Bees in the United States and Canada.

Vet Clin North Am Food Anim Pract. November 2021;37(3):451-465.

Tracy S Farone¹

¹ Grove City College, 100 Campus Drive, Grove City, PA 16127, USA. Electronic address: tsfarone@gcc.edu.

Abstract

A 2017 US Food and Drug Administration mandate requiring veterinary oversight for medically important antibiotics used in agricultural animals, including honey bees (Apis mellifera L.) created a "new" animal requiring veterinary involvement. Many resources are available describing medical formulations of antibiotics and other drugs used in the treatment of various honey bee maladies. The goal of this article is to summarize this information in an up-to-date, practical way for the clinician. At the time of this writing, only 3 antibiotics are approved for use in honey bees and require veterinary prescriptions or veterinary feed directives.

Keywords

Antibiotic resistance; Honey bee antibiotics; Veterinary feed directive (VFD); Veterinary honey bee medications;

Article Tools:

Medline

Email to me

Archives Highlights:

[Disease Caused by Filoviruses: An Update].
The Marburg and Ebola viruses belong to the Filoviridae family and are known to cause emerging zoonotic diseases. These viruses have a high case fatality rate and are easily transmissible from person to person, which makes them capable of triggering outbreaks, including in non-endemic regions, and are also considered agents of bioterrorism. This review aims to improve clinical knowledge and the approach to suspected cases of FD. Improved surveillance and preparedness for potential global outbreaks are essential measures to effectively respond to these public health threats and to ensure that healthcare professionals are well-informed and prepared to deal with these diseases.

Guide for nonswine practitioners to enhance swine disease diagnoses.
This review aims to help clinicians across the country that may not have an in-depth experience in swine medicine become more familiar with both common and novel pathogens, formulate a differential diagnosis based on the age of the animals and affected system (eg, respiratory, systemic, nervous, and enteric), select proper samples and laboratory testing, and interpret laboratory data to achieve a disease diagnosis in porcine patients.

Clinical characterization of a novel episodic ataxia in young working Cocker Spaniels.
The mean age at clinical onset was 4 months. Signs were acute and included episodic body swaying, titubation, cerebellar ataxia, wide-base stance, and hypermetria, all while mentation remained unaltered. Duration of episodes ranged from 30 minutes up to 24 hours, and their frequency varied from weekly to once every 5 months.

Investigating the relationship between canine training classes and post-adoption return rates in North American shelters
Of all the returned dogs, those who attended training were more likely to be returned for owner-related reasons (58.8?%), whereas dogs who did not attend training were more likely to be returned for animal-related reasons (78.9?%). While attending training classes at animal shelters may help to reduce behavioral returns, as shown by the shift in return reasons, they do not appear to reduce return rates significantly for the general shelter population.

Effective treatment with afoxolaner (NexGard) of Trixacarus caviae in a pet guinea pig.
The animal was treated with a single oral dose of 2.50 mg/kg afoxolaner, and the lesions, presence/absence of mites, and intensity of pruritus were evaluated periodically until 2 months post-treatment. A week after the medication, the lesions were milder, but pruritus was still present and was attributed to the healing process. Further examinations showed significant improvement with the complete remission of clinical signs and no mites at the microscopic examination after 4 weeks.